Sino‐Nasal Outcome Test–22: Translation, Cross‐cultural Adaptation, and Validation in Hebrew‐Speaking Patients. (23rd February 2016)

• Record Type: Journal Article
• Authors: Shapira Galitz, Yael; Halperin, Doron; Bavnik, Yosef; Warman, Meir
• Is Part Of: Otolaryngology--head and neck surgery. Volume 154:Number 5(2016:May)
• Page Start: 951
• Page End: 956
• Publication Date: 2016-02-23
• Subjects: chronic rhinosinusitis -- nasal polyps -- quality of life -- questionnaires -- SNOT‐22; Head -- Surgery -- Periodicals; Neck -- Surgery -- Periodicals; Otolaryngology -- Periodicals; 617.51
• DOI: 10.1177/0194599816629378
• Languages: English
• ISSNs: 0194-5998

Abstract

Abstract : Objective: To perform the translation, cross‐cultural adaptation, and validation of the Sino‐Nasal Outcome Test–22 (SNOT‐22) questionnaire to the Hebrew language. Study Design and Setting: A single‐center prospective cross‐sectional study. Subjects and Methods: Seventy‐three chronic rhinosinusitis (CRS) patients and 73 patients without sinonasal disease filled the Hebrew version of the SNOT‐22 questionnaire. Fifty‐one CRS patients underwent endoscopic sinus surgery, out of which 28 filled a postoperative questionnaire. Seventy‐three healthy volunteers without sinonasal disease also answered the questionnaire. Internal consistency, test‐retest reproducibility, validity, and responsiveness of the questionnaire were evaluated. Results: Questionnaire reliability was excellent, with a high internal consistency (Cronbach's alpha coefficient, 0.91‐0.936) and test‐retest reproducibility (Spearman's coefficient, 0.962). Mean scores for the preoperative, postoperative, and control groups were 50.44, 29.64, and 13.15, respectively ( P <. 0001 for CRS vs controls, P <. 001 for preoperative vs postoperative), showing validity and responsiveness of the questionnaire. Conclusion: The Hebrew version of SNOT‐22 questionnaire is a valid outcome measure for patients with CRS with or without nasal polyps.